Is Reject Shop Ltd set for further decline?

The share price of The Reject Shop has been punished in recent times. What does the future hold for the discount retailer?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What: Analysts at the Commonwealth Bank have cut Reject Shop Ltd (ASX:TRS) to "underweight" from "neutral" with a price target of $8.70, down from $10. The shares currently trade at $9.08. Concerns about weakening per-store metrics, management uncertainty, problematic inventory and the ability of the balance sheet to withstand any more weak trading periods were the key drivers for the downgrade.

So what?: The Reject Shop's share price has been punished over the past 12 months, falling from a high of $18.47 as investors questioned the company's future growth prospects. The continued deterioration in profitability per store has raised questions over the viability of The Reject Shop's aggressive store rollout plan. With falling profitability per store, it is likely that the newly appointed management team will significantly scale back the company's aspiration for 500 stores and instead focus on network optimisation. One analyst has suggested that the future store count could be cut to as low as 321, down 36%.

Now what?: Future earnings growth is highly dependent on The Reject Shop's ability to increase margins to previous high levels. In 2012, the company produced a 5% EBIT margin. However, in recent times margins have fallen to as low as 3% as the business struggles to get the right product mix. If margins return to levels seen in 2012, allowing for the continued aggressive store rollout, then the share price will increase significantly. However, if the business continues to see depressed margins, there is further downside. Until I see significant margin improvement, I will be watching from the sidelines.

Motley Fool contributor Bradley Murphy does not own shares in any company mentioned in this article.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »